title: Insulin vs sulfonylureas for second-line diabetes treatment--reply.
authors.affiliation: Veterans Health Administration-Tennessee Valley Healthcare System Geriatric Research Education Clinical Center, HSR&D Center, Nashville.
authors.forename: Christianne L
authors.initials: CL
authors.lastname: Roumie
authors.affiliation: Department of Biostatistics, Vanderbilt University, Nashville, Tennessee.
authors.forename: Robert A
authors.initials: RA
authors.lastname: Greevy
authors.affiliation: Department of Health Policy, Vanderbilt University, Nashville, Tennessee.
authors.forename: Marie R
authors.initials: MR
authors.lastname: Griffin
mesh_terms: D003920:Diabetes Mellitus / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D008297:Male; D008687:Metformin / Q000008:administration & dosage*
chemical_list: D007004:Hypoglycemic Agents; D008687:Metformin